Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
about
School closure policies at municipality level for mitigating influenza spread: a model-based evaluationEstimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel.Two years after pandemic influenza A/2009/H1N1: what have we learned?Increased transmissibility explains the third wave of infection by the 2009 H1N1 pandemic virus in England.Pandemic influenza A/H1N1pdm in Italy: age, risk and population susceptibility.Inferring influenza infection attack rate from seroprevalence dataHyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID miceSerum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza PandemicHigh incidence of severe influenza among individuals over 50 years of age.Cumulative incidence of pandemic influenza A (H1N1) 2009 by a community-based serological cohort study in Selenghe Province, MongoliaInfluenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.Searching for sharp drops in the incidence of pandemic A/H1N1 influenza by single year of age.Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy.Comparison of immune response by virus infection and vaccination to 2009 pandemic influenza A/H1N1 in childrenVero cell culture-derived pandemic influenza vaccines: preclinical and clinical development.2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane Capital, Laos.Structure of general-population antibody titer distributions to influenza A virus.IFITM3 and severe influenza virus infection. No evidence of genetic association.Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.Detecting a Surprisingly Low Transmission Distance in the Early Phase of the 2009 Influenza Pandemic.Population Serologic Immunity to human and avian H2N2 viruses in the United States and Hong Kong for Pandemic Risk Assessment.H7N9 Avian Influenza Virus Is Efficiently Transmissible and Induces an Antibody Response in Chickens.
P2860
Q30151697-653EC203-7465-4B11-A0A2-78652ABF1BBAQ30223476-C83B4D3E-41A9-4333-AB1E-1084B6D8EB26Q30223536-6DA5D3E8-7F27-4905-8282-F88F1E315297Q30224656-D8D97F96-28DA-4DC4-9146-9E9BE2EC71BCQ30352299-170CFEBA-92E5-490F-82BE-2BFB41C2BCF4Q30354383-EE5DCA6C-3E83-4E3C-8568-DFF14BE6B65AQ30361006-79517845-F908-47ED-B8A0-6A837CB6C425Q30361437-2890BECA-BB29-45CF-A7F5-0BA20A388C36Q30373917-267BF845-DF6B-487B-8C9F-81EA44372617Q30385942-F302BB91-B3FB-49DF-A5AB-1BF97AF0DD45Q30406838-1F6704BA-2DD4-416C-8E4D-3F92F0D9915DQ30413007-6566BEFD-0350-431E-8944-A1BFFF7599F6Q30416214-5D7B8E89-3952-43FD-8061-E82B44AE2891Q30417814-895E28C8-9237-4251-81CF-65EC3B405E5FQ30420192-3DABCCF7-8488-4C73-BBA6-00A930A9716BQ30420571-E97A139F-815B-4145-936F-F764F4C7F93FQ30425378-E87B4331-E8C1-4CAA-B5B1-869B78A7365DQ30427059-ED362328-4ACE-4DA5-A3A4-4C382A3A0C57Q30429058-97939FEF-7954-46B0-A85C-F1C5B66CA56BQ30430052-C83EB150-60B8-43D2-8B20-2CC0DD934B97Q39302806-E6BE6163-0D79-42C3-8677-3C24D6D4187AQ39523311-A8821B2F-3D5B-4DFE-87C5-CAEAE4DADC79Q40131070-6E271949-FDAE-41A6-A38F-A55B7AB0FE99Q40329744-8CC4E3B7-AB26-45CF-90E7-E40CF30366AFQ41960428-E6C0B06E-0F41-44EE-85FE-7A5C4B04EEE3Q54211362-04CCD40B-793D-429C-91C2-9EE87DEE3098Q54225666-691EE69D-E17D-4585-9B9A-95071991650D
P2860
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
@ast
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
@en
type
label
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
@ast
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
@en
prefLabel
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
@ast
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
@en
P2093
P2860
P356
P1476
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?
@en
P2093
Andrew Amato-Gauci
Angus Nicoll
Eeva Broberg
P2860
P304
P356
10.1128/CVI.05072-11
P577
2011-06-08T00:00:00Z